Colon Cancer

Immune checkpoint inhibitors for patients with isolated peritoneal carcinomatosis from dMMR/MSI-H colorectal cancer, a BIG-RENAPE collaboration
Solenn Barraud, David Tougeron, Laurent Villeneuve, Clarisse Eveno, Arnaud Bayle, Yann Parc, Marc Pocard, Thierry André, Romain Cohen

Combined liver resection and cytoreductive surgery with HIPEC for metastatic colorectal cancer: Results of a worldwide analysis of 565 patients from the Peritoneal Surface Oncology Group International (PSOGI).
Lo Dico R, Faron M, Yonemura Y, Glehen O, Pocard M, Sardi A, Hübner M, Baratti D, Liberale G, Kartheuser A, de Hingh I, Sugarbaker P, Ceelen W, Moran B, Robella M, Quenet F, Sideris L, Goere D, Limbert M, Sammartino P, Morris D; PSOGI Working Group, BIG RENAPE Working Group. Eur J Surg Oncol. 2021 Jan;47(1):89-100. doi: 10.1016/j.ejso.2020.07.038. Epub 2020 Aug 26. PMID: 32943276

Designing HIPEC regimens for colon cancer: Is the available evidence being appropriately considered?
Lana Bijelic, Oriol Crusellas, Isabel Ramos, Kurt Van der Speeten, Pedro Barrios, Domenico Sabia. SODA
Free article

The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R.
Ann Surg Oncol. 2014 Dec;21(13):4195-201.

Accord d’experts français pour la prise en charge des métastases péritonéales de cancers colo-rectaux
Journal de chirurgie Viscérale 2019
Abboud K, André T, Brunel M, Ducreux M, Eveno C, Glehen O, Goéré D, Gornet JM, Lefevre JH, Mariani P, Pinto A, Quenet F, Sgarbura O, Ychou M, Pocard M.

Management of colorectal peritoneal metastases: Expert opinion.
Abboud K, André T, Brunel M, Ducreux M, Eveno C, Glehen O, Goéré D, Gornet JM, Lefevre JH, Mariani P, Pinto A, Quenet F, Sgarbura O, Ychou M, Pocard M.
J Visc Surg. 2019 Oct;156(5):377-379.

Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes.
Levine EA, Blazer DG 3rd, Kim MK, Shen P, Stewart JH 4th, Guy C, Hsu DS.
J Am Coll Surg. 2012 Apr;214(4):599-606; discussion 606-7. doi: 10.1016/j.jamcollsurg.2011.12.028. Epub 2012 Feb 17.
PMID:22342786
Free PMC Article

Appendiceal goblet cell carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Randle RW, Griffith KF, Fino NF, Swett KR, Stewart JH 4th, Shen P, Levine EA, Votanopoulos KI.
J Surg Res. 2015 Jun 15;196(2):229-34. doi: 10.1016/j.jss.2015.03.051. Epub 2015 Mar 24.
PMID:25881787
Free PMC Article

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database.
Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, Saltz L, Punt CJA, Koopman M, Tournigand C, Tebbutt NC, Diaz-Rubio E, Souglakos J, Falcone A, Chibaudel B, Heinemann V, Moen J, De Gramont A, Sargent DJ, Grothey A; Analysis and Research in Cancers of the Digestive System (ARCAD) Group.
Lancet Oncol. 2016 Dec;17(12):1709-1719.

A Simplified Preoperative Assessment Predicts Complete Cytoreduction and Outcomes in Patients with Low-Grade Mucinous Adenocarcinoma of the Appendix.
Dineen SP, Royal RE, Hughes MS, Sagebiel T, Bhosale P, Overman M, Matamoros A, Mansfield PF, Fournier KF.
Ann Surg Oncol. 2015 Oct;22(11):3640-6. doi: 10.1245/s10434-015-4446-y. Epub 2015 Feb 20.
PMID: 25698402
Free PMC Article

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL, Wisselink DD, Punt CJA, Snaebjornsson P, Crezee J, Aalbers AGJ, Brandt A, Bremers AJA, Burger JWA, Fabry HFJ, Ferenschild F, Festen S, van Grevenstein WMU, Hemmer PHJ, de Hingh IHJT, Kok NFM, Musters GD, Schoonderwoerd L, Tuynman JB, van de Ven AWH, van Westreenen HL, Wiezer MJ, Zimmerman DDE, van Zweeden AA, Dijkgraaf MGW, Tanis PJ; COLOPEC collaborators group.
Lancet Gastroenterol Hepatol. 2019 Oct;4(10):761-770. doi: 10.1016/S2468-1253(19)30239-0.

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial.
Cashin PH, Mahteme H, Spång N, Syk I, Frödin JE, Torkzad M, Glimelius B, Graf W.
Eur J Cancer. 2016 Jan;53:155-62. doi: 10.1016/j.ejca.2015.09.017. Epub 2016 Jan 2.

Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy?
Goéré D, Malka D, Tzanis D, Gava V, Boige V, Eveno C, Maggiori L, Dumont F, Ducreux M, Elias D.
Ann Surg. 2013 Jun;257(6):1065-71. doi: 10.1097/SLA.0b013e31827e9289.

8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H.
Ann Surg Oncol. 2008 Sep;15(9):2426-32. doi: 10.1245/s10434-008-9966-2. Epub 2008 Jun 3.

Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, Zoetmulder FA.
J Clin Oncol. 2003 Oct 15;21(20):3737-43.
PMID: 14551293

Legal policies